MedPath

Pivotal Response Treatment for Individuals With Intellectual Disabilities

Not Applicable
Completed
Conditions
Speech Delay
Intellectual Disabilities
Language Disorder
Interventions
Behavioral: Pivotal Response Treatment (PRT)
Registration Number
NCT01988623
Lead Sponsor
Stanford University
Brief Summary

The investigators will assess the efficacy of Pivotal Response Treatment (PRT) in the treatment of communication deficits in children with intellectual disabilities. By collecting information about parent and child functioning before and after PRT, The investigators will be able to determine whether the intervention is effective in improving child communication and reducing parent stress.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria

Not provided

Read More
Exclusion Criteria
  • medically unstable (such as having unstable seizures)
  • primary diagnosis of Autism Spectrum Disorder (ASD) is exclusionary as determined by the investigators
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Pivotal Response Treatment (PRT)Pivotal Response Treatment (PRT)-
Primary Outcome Measures
NameTimeMethod
Change from Baseline on the Social Responsiveness Scale (SRS) at 6, 12, and 24 weeks6, 12 and 24 weeks
Change from Baseline on the Clinical Global Impression Scale at 6, 12, and 24 weeks6, 12, and 24 weeks
Change from Baseline on the MacArthur-Bates Communication Development Inventory at 6, 12, and 24 weeks6, 12 and 24 weeks
Change from Baseline in communication during parent-child and clinician-child interactions at 6, 12, and 24 weeks6, 12 and 24 weeks
Secondary Outcome Measures
NameTimeMethod
Change from Baseline on the Vineland Adaptive Behavior Scales, Second Edition (VABS-II) at 6, 12, and 24 weeks6, 12 and 24 weeks
Change from Baseline on the Parenting Stress Index (PSI) at 6, 12, and 24 weeks6, 12, and 24 weeks
Change from Baseline on the Family Empowerment Scale (FES) at 6, 12, and 24 weeks6, 12, and 24 weeks

Trial Locations

Locations (1)

Stanford University School of Medicine

🇺🇸

Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath